Actionnariat et activité des initiés pour Crinetics Pharmaceuticals, Inc. (CRNX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $84.95 |
| Capitalisation | $9.0B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-01 | WIERENGA WENDELL | D-Return | 116,146 | $9.9M |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 5,925 | $504K |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 12,500 | $290K |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 12,500 | $290K |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 17,500 | $354K |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 17,500 | $320K |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 17,500 | $356K |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 12,500 | $559K |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 10,350 | $335K |
| 2026-09-01 | WIERENGA WENDELL | D-Return | 9,730 | $349K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $12.2M | $14.2M | $45.0M | $40.3M | $93.1M | $200.7M | $32.7M | $54.9M | $264.5M | $101.5M |
| Placements à Court Terme | 0 | 0 | $118.9M | $78.1M | $77.8M | $133.0M | $301.8M | $503.7M | $1.09B | $926.4M |
| Créances | $72000 | $734000 | 0 | $1.4M | $1.8M | $2.0M | $2.4M | $9.4M | $8.5M | $592000 |
| Stocks | $98000 | $141000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.0M |
| Actifs Courants | $12.4M | $15.2M | $166.7M | $123.3M | $177.5M | $344.7M | $345.2M | $574.2M | $1.38B | $1.05B |
| Immobilisations Corporelles | $224000 | $400000 | $4.2M | $6.5M | $5.4M | $4.7M | $5.0M | $57.4M | $55.6M | $54.8M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $12.6M | $15.6M | $171.4M | $130.4M | $183.4M | $351.0M | $352.2M | $635.4M | $1.43B | $1.14B |
| Dettes Fournisseurs | $340000 | $403000 | $1.5M | $2.7M | $3.5M | $4.3M | $6.9M | $6.5M | $5.9M | $22.6M |
| Dette à Court Terme | $49000 | 0 | 0 | $724000 | 0 | $939000 | $1.1M | $4.2M | 0 | $6.5M |
| Passifs Courants | $890000 | $897000 | $7.9M | $8.3M | $10.5M | $16.0M | $27.7M | $43.9M | $59.7M | $85.1M |
| Dette à Long Terme | $163000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $18.8M | $30.6M | $11.2M | $13.2M | $14.5M | $19.1M | $35.8M | $96.2M | $109.8M | $143.4M |
| Réserves | -$7.1M | -$16.3M | -$43.4M | -$93.8M | -$167.6M | -$275.3M | -$439.2M | -$653.7M | -$952.1M | -$1.42B |
| Capitaux Propres | -$6.2M | -$15.0M | -$43.4M | $117.1M | $168.9M | $331.9M | $316.3M | $539.1M | $1.32B | $992.1M |
| Dette Totale | $212000 | 0 | 0 | $5.6M | $4.0M | $4.0M | $3.1M | $51.7M | $51.7M | $48.5M |
| Dette Nette | -$11.9M | -$14.2M | -$163.9M | -$112.8M | -$166.9M | -$329.7M | -$331.4M | -$506.8M | -$1.30B | -$979.3M |
| Fonds de Roulement | $11.5M | $14.3M | $158.8M | $115.0M | $167.0M | $328.7M | $317.5M | $530.2M | $1.32B | $963.3M |
Santé financière
| Dette / Capitaux propres | 0.04 |
| Ratio de liquidité | 15.57 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 16.09 |
Rentabilité
| Rentabilité des capitaux propres | -44.22% |
| Rentabilité du capital investi | -43.98% |
| Rentabilité des actifs | -37.95% |
| Marge brute | 99.16% |
| Marge opérationnelle | -1302.52% |
| Marge nette | -1189.88% |
Entreprises liées: ACAD · AKRO · DYN · IMVT · KYMR · NAMS · PRAX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CRNX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions